CR9759A - Vacuna rotavirus que induce la proteccion cruzada heterotipica - Google Patents
Vacuna rotavirus que induce la proteccion cruzada heterotipicaInfo
- Publication number
- CR9759A CR9759A CR9759A CR9759A CR9759A CR 9759 A CR9759 A CR 9759A CR 9759 A CR9759 A CR 9759A CR 9759 A CR9759 A CR 9759A CR 9759 A CR9759 A CR 9759A
- Authority
- CR
- Costa Rica
- Prior art keywords
- heterotipic
- rotavirus vaccine
- rotavirus
- vaccine inducing
- crossed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La invencion proporciona un procedimiento de induccion de una respuesta inmune contra una cepa de rotavirus, comprendiendo el procedimiento la administracion a un sujeto de una composicion que comprende una cepa de rotavirus atenuado de un tipo GxPy, generando dicha composicion una respuesta inmune contra una cepa de rotavirus que ni es un tipo Gx ni Py.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0516944A GB0516944D0 (en) | 2005-08-17 | 2005-08-17 | Vaccine |
GB0521164A GB0521164D0 (en) | 2005-10-18 | 2005-10-18 | Vaccine |
GB0608962A GB0608962D0 (en) | 2006-05-05 | 2006-05-05 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9759A true CR9759A (es) | 2008-05-05 |
Family
ID=37757924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9759A CR9759A (es) | 2005-08-17 | 2008-02-22 | Vacuna rotavirus que induce la proteccion cruzada heterotipica |
Country Status (25)
Country | Link |
---|---|
US (1) | US20090028828A1 (es) |
EP (2) | EP2233153B1 (es) |
JP (1) | JP5519934B2 (es) |
KR (1) | KR20080036648A (es) |
AR (1) | AR054916A1 (es) |
AU (1) | AU2006281566B2 (es) |
BR (1) | BRPI0615203A2 (es) |
CA (1) | CA2619751C (es) |
CR (1) | CR9759A (es) |
CY (1) | CY1116135T1 (es) |
DK (1) | DK2233153T3 (es) |
EA (1) | EA014328B1 (es) |
ES (1) | ES2534637T3 (es) |
HR (1) | HRP20150310T1 (es) |
IL (1) | IL189289A0 (es) |
MA (1) | MA29700B1 (es) |
MX (1) | MX2008002270A (es) |
NO (1) | NO20080754L (es) |
PE (1) | PE20070235A1 (es) |
PL (1) | PL2233153T3 (es) |
PT (1) | PT2233153E (es) |
SG (1) | SG163571A1 (es) |
SI (1) | SI2233153T1 (es) |
TW (1) | TW200740457A (es) |
WO (1) | WO2007020078A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0107510D0 (en) | 2001-03-26 | 2001-05-16 | Univ Bristol | New elongase gene and a process for the production of -9-polyunsaturated fatty acids |
WO2009042202A2 (en) | 2007-09-25 | 2009-04-02 | Aridis Pharmaceuticals | Formulations for preservation of rota virus |
US9311112B2 (en) * | 2009-03-16 | 2016-04-12 | Apple Inc. | Event recognition |
BR112013027457A2 (pt) * | 2011-04-28 | 2019-09-24 | Int Medica Foundation | preparação de vacina, e, métodos de fabricar uma preparação de vacina, e de vacinar um mamífero |
CN110227152A (zh) * | 2012-04-23 | 2019-09-13 | 巴拉特生物技术国际有限公司 | 轮状病毒疫苗组合物及其制备方法 |
WO2017062246A1 (en) | 2015-10-05 | 2017-04-13 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Human rota virus g9p[6] strain and use as a vaccine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69130068T2 (de) * | 1990-11-16 | 1999-01-07 | Children's Hospital Medical Center, Cincinnati, Ohio | Humane rotativen, impfstoffe und methoden |
UA77388C2 (uk) * | 1999-08-17 | 2006-12-15 | Глаксосмітклайн Байолоджікалз С.А. | Послаблена популяція ротавірусів людини, ротавірус та вакцинна композиція, що містить живий послаблений ротавірус людини |
EP1660123B1 (en) * | 2003-09-02 | 2013-03-13 | GlaxoSmithKline Biologicals s.a. | Rotavirus vaccine |
-
2006
- 2006-08-15 KR KR1020087006496A patent/KR20080036648A/ko not_active Application Discontinuation
- 2006-08-15 BR BRPI0615203-1A patent/BRPI0615203A2/pt not_active Application Discontinuation
- 2006-08-15 PT PT101599496T patent/PT2233153E/pt unknown
- 2006-08-15 EP EP10159949.6A patent/EP2233153B1/en active Active
- 2006-08-15 WO PCT/EP2006/008094 patent/WO2007020078A2/en active Application Filing
- 2006-08-15 DK DK10159949T patent/DK2233153T3/da active
- 2006-08-15 PE PE2006000993A patent/PE20070235A1/es not_active Application Discontinuation
- 2006-08-15 JP JP2008526443A patent/JP5519934B2/ja active Active
- 2006-08-15 US US12/063,602 patent/US20090028828A1/en not_active Abandoned
- 2006-08-15 ES ES10159949.6T patent/ES2534637T3/es active Active
- 2006-08-15 EP EP06776899A patent/EP1915173A2/en not_active Ceased
- 2006-08-15 TW TW095129956A patent/TW200740457A/zh unknown
- 2006-08-15 SG SG201004843-7A patent/SG163571A1/en unknown
- 2006-08-15 CA CA2619751A patent/CA2619751C/en active Active
- 2006-08-15 PL PL10159949T patent/PL2233153T3/pl unknown
- 2006-08-15 SI SI200631912T patent/SI2233153T1/sl unknown
- 2006-08-15 AR ARP060103557A patent/AR054916A1/es not_active Application Discontinuation
- 2006-08-15 AU AU2006281566A patent/AU2006281566B2/en not_active Ceased
- 2006-08-15 MX MX2008002270A patent/MX2008002270A/es unknown
- 2006-08-15 EA EA200800320A patent/EA014328B1/ru not_active IP Right Cessation
-
2008
- 2008-02-05 IL IL189289A patent/IL189289A0/en unknown
- 2008-02-12 NO NO20080754A patent/NO20080754L/no not_active Application Discontinuation
- 2008-02-13 MA MA30653A patent/MA29700B1/fr unknown
- 2008-02-22 CR CR9759A patent/CR9759A/es not_active Application Discontinuation
-
2015
- 2015-03-18 HR HRP20150310TT patent/HRP20150310T1/hr unknown
- 2015-03-23 CY CY20151100289T patent/CY1116135T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1116135T1 (el) | 2017-02-08 |
WO2007020078A3 (en) | 2007-05-24 |
PE20070235A1 (es) | 2007-04-04 |
KR20080036648A (ko) | 2008-04-28 |
MX2008002270A (es) | 2008-03-27 |
CA2619751A1 (en) | 2007-02-22 |
EP1915173A2 (en) | 2008-04-30 |
TW200740457A (en) | 2007-11-01 |
DK2233153T3 (da) | 2015-04-27 |
AU2006281566B2 (en) | 2011-09-01 |
SG163571A1 (en) | 2010-08-30 |
AU2006281566A1 (en) | 2007-02-22 |
AR054916A1 (es) | 2007-07-25 |
EA014328B1 (ru) | 2010-10-29 |
IL189289A0 (en) | 2008-06-05 |
JP2009504701A (ja) | 2009-02-05 |
US20090028828A1 (en) | 2009-01-29 |
PL2233153T3 (pl) | 2015-06-30 |
EP2233153B1 (en) | 2015-01-21 |
BRPI0615203A2 (pt) | 2011-05-10 |
SI2233153T1 (sl) | 2015-05-29 |
PT2233153E (pt) | 2015-04-20 |
ES2534637T3 (es) | 2015-04-27 |
HRP20150310T1 (hr) | 2015-06-19 |
NO20080754L (no) | 2008-05-15 |
MA29700B1 (fr) | 2008-08-01 |
WO2007020078A2 (en) | 2007-02-22 |
JP5519934B2 (ja) | 2014-06-11 |
EA200800320A1 (ru) | 2008-10-30 |
CA2619751C (en) | 2016-07-05 |
EP2233153A1 (en) | 2010-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR9759A (es) | Vacuna rotavirus que induce la proteccion cruzada heterotipica | |
JO3257B1 (ar) | مركبات وتركيبات كمعدلات لفاعلية tlr | |
DK2459216T3 (da) | Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer | |
ECSP077179A (es) | Co-cultivos manejados de organismos que tienen efectos profilacticos y promotores de la salud | |
AR075169A1 (es) | Capas de saccharomyces cerevisiae con aptitudes fitosanitarias | |
CO6160335A2 (es) | Vacuna | |
CR10347A (es) | Anticuerpos contra el peptidob-amiloide | |
TW200806316A (en) | Yeast-based vaccine for inducing an immune response | |
BRPI0815008B8 (pt) | vacinas multiméricas com múltiplos epítopos contra influenza | |
TW200603825A (en) | Prrsv subunit vaccines | |
MX2009003378A (es) | Concentrados en suspension para la mejora de la absorcion por la raiz de principios activos agroquimicos. | |
BRPI0821240B8 (pt) | formas mutantes de estreptolisina o | |
EA201400510A1 (ru) | Водная фотозащитная композиция для личной гигиены | |
AR056712A1 (es) | Composicion y vacuna efectiva para tratar prevenir o mejorar la inoculacion del virus de la influenza canina metodo pra generar un inmunogen del virus dela influenza equina o del virus de la influenza canina modelo de la inoculacion util para determinar la eficacia de la composicion contra el virus | |
PH12015501875A1 (en) | Acellular pertussis vaccine | |
CL2007002710A1 (es) | Formulacion inmunogenica que confiere proteccion contra la infeccion o patologia causada por el virus respiratorio sincicial (vrs) que comprende una cepa recombinante atenuada de mycobacterium; y uso de la formulacion inmunogenica para preparar una vacuna para prevenir, tratar o atenuar infecciones del vrs. | |
AR052639A1 (es) | Composicion vacunal contra el virus de la hepatitis c. | |
PH12017550047A1 (en) | Use of taurine in prevention and/or treatment of diseases induced by viruses of genus coronavirus and/or genus rotavirus | |
WO2009044272A3 (en) | Laser-based vaccine adjuvants | |
CL2020002876A1 (es) | Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420) | |
BRPI0414073A (pt) | método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo | |
MX2012002630A (es) | Regimen de inmunizacion por sensibilizacion-refuerzo heterologa contra el virus de la lengua azul. | |
CL2009000965A1 (es) | Tableta oral compuesta por un compuesto i que comprende un 10 a 20% en peso de la tableta o su sal farmaceuticamente aceptable, que comprende ademas de un agente aglutinante, un desintegrante, un diluyente; proceso de preparacion de la tableta; y su uso en el tratamiento de vih y enfermedades inflamatorias. | |
CR20110501A (es) | Composiciones para la protección de cosechas, método para su aplicación y uso de dichas composiciones para protección de cosechas | |
Ahmed et al. | Hepatoprotective fraction from aerial parts of Delonix regia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |